EP0417152A1 - New cyclites derived from streptomycetes, their preparation and use - Google Patents

New cyclites derived from streptomycetes, their preparation and use

Info

Publication number
EP0417152A1
EP0417152A1 EP19890906108 EP89906108A EP0417152A1 EP 0417152 A1 EP0417152 A1 EP 0417152A1 EP 19890906108 EP19890906108 EP 19890906108 EP 89906108 A EP89906108 A EP 89906108A EP 0417152 A1 EP0417152 A1 EP 0417152A1
Authority
EP
European Patent Office
Prior art keywords
dsm
compound
group
nutrient solution
cyclites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19890906108
Other languages
German (de)
French (fr)
Inventor
Susanne Grabley
Joachim Wink
Peter Hammann
Carlo Giani
Klaus HÜTTER
Axel Zeeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of EP0417152A1 publication Critical patent/EP0417152A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/06Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/02Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/487Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/497Saturated compounds containing a keto group being part of a ring containing hydroxy groups a keto group being part of a six-membered ring

Definitions

  • Cyclites are pseudosugars, i.e. Derivatives of saccharides in which the pyranoserine oxygen is replaced by a methylene group. These substances are potential glycosidase ether [H. Paulsen, Liebig's Analen der Chemie, p. 125 (1987)] or glyoxylase inhibitors [T.Takeushi, J. Antibiot. 28: 737 (1975)]. These substances are essentially synthesized by Streptomycetes in nature.
  • the invention thus relates to:
  • R 1 can be an oxo group or a hydroxy group
  • R 2 can be a methyl group or an acetoxymethyl group
  • R 3 and R 4 can be hydrogen or together a double bond
  • R 5 can be an oxo group or a hydroxyl group, except for the compounds in which
  • R 1 is an oxo group
  • R 2 is a methyl group
  • R 3 and R 4 are hydrogen and
  • the compound of general formula I is produced by different St reptomycete strains, which were deposited with the German Collection of Microorganisms with the numbers DSM 4351, DSM 4354 and DSM 4353 under the conditions of the Budapest Treaty.
  • Streptomyces DSM 4351 synthesizes the compound of the formula
  • R 1 is an oxo group
  • R 2 is a methyl group
  • R 3 and
  • R 4 together are a double bond and R 5 is a hydroxy group.
  • Streptomyces DSM 4354 produces the compound of the formula I in which R 1 is a hydroxyl group, R 2 is a methyl group or an acetoxymethyl group, R 3 and R 4 are together a double bond and R 5 is an oxo group.
  • Streptomyces DSM 4353 produces the compound of formula I in which R 1 is an oxo group, R 2 is a methyl group, R 3 and
  • R 4 is hydrogen and R 5 is a hydroxy group.
  • mutants and variants can also be used, provided they synthesize the compound of the general formula I.
  • Such mutants can be known in a manner known per se by physical means, for example radiation, such as with ultraviolet or X-rays, or chemical mutagens, for example ethyl methanesulfonate (EMS), N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) or 2-Hydroxy-4-methoxybenzophenone (MOB) can be generated.
  • EMS ethyl methanesulfonate
  • MNNG N-methyl-N'-nitro-N-nitroso-guanidine
  • MOB 2-Hydroxy-4-methoxybenzophenone
  • the nutrient solution can contain, for example, chlorides, carbonates, sulfates or phosphates of the alkali or alkaline earth metals, iron, zinc and manganese as additional inorganic salts.
  • the formation of the compound of general formula I proceeds particularly well in a nutrient solution, the oatmeal in concentrations of 0.5 to 6%. preferably 2 to 4%, soy flour in concentrations of 0.1 to 4%, preferably 0.5 to 2%. and contains trace elements, each based on the weight of the entire nutrient solution.
  • the fermentation is carried out aerobically, for example submerged with shaking or stirring in shake flasks or fermenters, optionally with the introduction of air or oxygen.
  • the fermentation can take place in a temperature range from about 18 to 40 ° C., preferably at about 25 to 30 ° C., in particular at 28 to 30 ° C.
  • the microorganism is cultivated under the conditions mentioned until the stationary phase is reached, about 60 to 120 hours, preferably 70 to 75 hours.
  • Cultivation is advantageously carried out in several stages, ie one or more precultures are first prepared in a liquid nutrient medium, which are then inoculated into the actual production medium, the main culture, for example in a volume ratio of 1:10.
  • the preculture is obtained, for example, by inoculating a spilled mycelium in a nutrient solution and allowing it to grow for about 48 to 72 hours.
  • the exported mycelium can be obtained by using the Let the strain grow on a solid or liquid culture medium, for example yeast-malt agar, for about 7 days.
  • the course of the fermentation can be monitored on the basis of the pH value of the culture or the mycelium volume, by thin-layer chromatography or by testing the biological activity.
  • the cyclites of the general formula I are isolated from the culture medium by known methods, taking into account the chemical, physical and biological properties of the products.
  • the cyclites of the general formula I are present in the mycelium or in the culture broth. They can be extracted from the unfiltered culture broth with an organic solvent which is immiscible or only slightly miscible with water, such as chloroform or ethyl acetate.
  • an organic solvent which is immiscible or only slightly miscible with water, such as chloroform or ethyl acetate.
  • it is advantageous to separate the culture broth from the mycelium for example by centrifuging or filtering, preferably with the addition of
  • the compound of general formula I can then be isolated from the supernatant or filtrate, expediently in the slightly acidic to neutral pH range, preferably at pH 6 to 7.
  • organic solvents which are poorly or immiscible with water, in particular chlorinated hydrocarbon such as chloroform or methylene chloride or esters such as ethyl acetate or acetone.
  • chlorinated hydrocarbon such as chloroform or methylene chloride or esters such as ethyl acetate or acetone.
  • the extracts if appropriate after evaporation and taking up in a polar organic solvent, are freed from strongly lipophilic constituents by precipitation with a non-polar solvent, advantageously a hydrocarbon such as petroleum ether, which can make up to about 80% of the total extract.
  • the cyclites can be isolated from the residue by chromatography.
  • the cyclites can also be obtained from the adsorber resins by adsorption onto commercially available resins Culture broth are isolated. It has also proven advantageous to dry the fermenter content mentioned, for example by spray drying or freeze drying.
  • the cyclites of the general formula I are oily and readily soluble in methanol, acetone, DMSO, dioxane and chloroform, but little in water and not in alkanes.
  • the substances are stable in the solid state and also as a solution in the pH range from 3 to 9, in particular from 5 to 8.
  • the growth-regulating effect can be shown particularly well on dicotyledonous plants such as cress.
  • a) Preparation of a spore suspension of a producer strain 100 ml nutrient solution (4 g yeast extract, 10 g malt extract, 4 g glucose, 1 1 tap water, pH before sterilization 7.3) in a 500 ml Erlenmeyer flask are inoculated with the strain and 72 Incubated for hours at 27 ° C and 120 rpm on the rotating shaker. Subsequently, 20 ml of culture liquid in a 500 ml Erlenmeyer flask with the nutrient medium of the above composition, to which 20 g of agar / 1 was added for solidification, are uniform distributed and decanted. The cultures are incubated at 27 ° C for 10 to 14 days. The spores of a flask formed after this time are washed off with 500 ml of deionized water, which contains a drop of a commercially available nonionic surfactant, used immediately or kept at -22 ° C.
  • a 10 1 fermenter is operated under the following conditions:
  • Ventilation 4 1 air / min.
  • the foam development can be suppressed by repeatedly adding a few drops of ethanolic polyol solution.
  • the yields are approx. 20 mg / 1.
  • the culture broth is filtered with the addition of 2% Celite as a filter aid.
  • the mycelium is extracted with acetone, the organic phase is evaporated and the aqueous residue is extracted with ethyl acetate.
  • the culture filtrate is dried and dissolved in MeOH.
  • the crude product is chromatographed on a silica gel column (silica gel 60, Macherey-Nagel) with ethyl acetate / hexane (1: 2; v: v).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

De nouvelles cyclites possédant une action régulatrice sur la croissance, notamment dans des plantes dicotylédones comme le cresson, peuvent être isolées à partir d'une solution nutritive de streptomycètes.New cyclites with a growth-regulating action, especially in dicotyledonous plants such as watercress, can be isolated from a nutritive solution of streptomycetes.

Description

Beschreibungdescription
Neue Cyclite aus Streptomyceten, ihre Herstellung und ihre VerwendungNew cyclites from Streptomycetes, their production and their use
Cyclite sind Pseudozucker, d.h. Derivate von Sacchariden, bei denen der Pyranoseringsauerstoff durch eine Methylengruppe ersetzt ist. Diese Stoffe sind potentielle Glycosidaseheramer [H. Paulsen, Liebig's Analen der Chemie, S. 125 (1987)] oder Glyoxylaseinhibitoren [T.Takeushi, J. Antibiot. 28, 737 (1975)]. Diese Stoffe werden in der Natur im wesentlichen von Streptomyceten synthetisiert.Cyclites are pseudosugars, i.e. Derivatives of saccharides in which the pyranoserine oxygen is replaced by a methylene group. These substances are potential glycosidase ether [H. Paulsen, Liebig's Analen der Chemie, p. 125 (1987)] or glyoxylase inhibitors [T.Takeushi, J. Antibiot. 28: 737 (1975)]. These substances are essentially synthesized by Streptomycetes in nature.
Umezawa et al. beschreiben in The Journal of AntibioticsUmezawa et al. describe in The Journal of Antibiotics
[ 27, 579 (197-4)] ein Hydroxymethyltrihydroxycyclohexanon mit einem Drehwert [α]2 D 0 von -168°, das von Streptomyces filiplnensis in das Kulturfiltrat ausgeschieden wird. Eine Verbindung mit der gleichen Strukturformel, allerdings ohne Angabe eines Drehwertes, wird in der japanischen Patentanmeldung Sho-49(=1974)-54587 beschrieben. Dort wird ebenfalls erwähnt, daß diese Verbindung das Pflanzenwachstum beeinflußt.[27, 579 (197-4)] a hydroxymethyltrihydroxycyclohexanone with a rotation [α] 2 D 0 of -168 °, which is excreted into the culture filtrate by Streptomyces filiplnensis. A compound with the same structural formula, but without specifying a rotation value, is described in Japanese patent application Sho-49 (= 1974) -54587. It is also mentioned there that this compound influences plant growth.
Keller-Schierlein et al. [Helvetica Chimica Acta 69 , 1829 (1986)7 haben aus Streptomyces albus ein Methyltrihydroxycyclohexanon mit einem Drehwert von [α]2 D 0 = -106° (in Methanol) isoliert, allerdings wurde diesem Produkt keine die physiologische Aktivität von Pflanzen beeinflussende Eigenschaften zugeordnet.Keller-Schierlein et al. [Helvetica Chimica Acta 69, 1829 (1986) 7 have isolated a methyltrihydroxycyclohexanone with a rotation value of [α] 2 D 0 = -106 ° (in methanol) from Streptomyces albus, but no properties influencing the physiological activity of plants have been assigned to this product .
Aus Streptomyceten konnten, wie im folgenden beschrieben, weitere Cyclite mit pharmakologischer und überraschend guter wachstumsregulatorischer Wirkung bei Pflanzen isoliert werden. ie Erfindung betrifft somit:As described below, further cyclites with pharmacological and surprisingly good growth-regulating activity in plants could be isolated from Streptomycetes. The invention thus relates to:
1. Die Verbindung der allgemeinen Formel I,1. The compound of general formula I
in der unabhängig voneinander in the independently of each other
R1 eine Oxogruppe oder eine Hydroxygruppe, R2 eine Methylgruppe oder eine Acetoxymethylgruppe, R3 und R4 Wasserstoff oder gemeinsam eine Doppelbindung und R5 eine Oxogruppe oder eine Hydroxygruppe sein können, ausgenommen die Verbindungen, in derR 1 can be an oxo group or a hydroxy group, R 2 can be a methyl group or an acetoxymethyl group, R 3 and R 4 can be hydrogen or together a double bond and R 5 can be an oxo group or a hydroxyl group, except for the compounds in which
R1 eine Oxogruppe, R2 eine Methylgruppe,R 1 is an oxo group, R 2 is a methyl group,
R3 und R4 Wasserstoff undR 3 and R 4 are hydrogen and
R5 eine Hydroxygruppe ist und die den Drehwert [α]2 D 0 = -106° (in Methanol, c=0,45) hat.R 5 is a hydroxy group and has the rotation value [α] 2 D 0 = -106 ° (in methanol, c = 0.45).
2. Ein Verfahren zur Herstellung der unter 1 charakterisierten Verbindung der allgemeinen Formel I, das dadurch gekennzeichnet ist, daß ein Stamm der Gattung Streptomyces in einer Nährlösung kultiviert wird bis sich die genannte Verbindung in der Nährlösung anhäuft.2. A process for the preparation of the compound of general formula I characterized under 1, which is characterized in that a strain of the genus Streptomyces is cultivated in a nutrient solution until said compound accumulates in the nutrient solution.
3. Die Verwendung der unter 1 charakterisierten Verbindung der allgemeinen Formel I als wachstumsregulierender Stoff. Im folgenden wird die Erfindung detailliert beschrieben, insbesondere in ihren bevorzugten Ausführungsformen. Ferner wird die Erfindung in den Ansprüchen definiert.3. The use of the compound of general formula I characterized under 1 as a growth-regulating substance. The invention is described in detail below, in particular in its preferred embodiments. The invention is further defined in the claims.
Die Verbindung der allgemeinen Formel I wird von unterschiedlichen St reptomyceten-Stämmen hergestellt, die jeweils bei der Deutschen Sammlung von Mikroorganismen mit den Nummern DSM 4351, DSM 4354 und DSM 4353 unter den Bedingungen des Budapester Vertrages hinterlegt wurden.The compound of general formula I is produced by different St reptomycete strains, which were deposited with the German Collection of Microorganisms with the numbers DSM 4351, DSM 4354 and DSM 4353 under the conditions of the Budapest Treaty.
Streptomyces DSM 4351 synthetisiert die Verbindung der FormelStreptomyces DSM 4351 synthesizes the compound of the formula
I. in der R1 eine Oxogruppe, R2 eine Methylgruppe, R3 undI. R 1 is an oxo group, R 2 is a methyl group, R 3 and
R4 gemeinsam eine Doppelbindung sowie R5 eine Hydroxygruppe sind.R 4 together are a double bond and R 5 is a hydroxy group.
Streptomyces DSM 4354 stellt die Verbindung der Formel I her, in der R1 eine Hydroxygruppe, R2 eine Methylgruppe oder eine Acetoxymethylgruppe, R3 und R4 gemeinsam eine Doppelbindung sowie R5 eine Oxogruppe sind.Streptomyces DSM 4354 produces the compound of the formula I in which R 1 is a hydroxyl group, R 2 is a methyl group or an acetoxymethyl group, R 3 and R 4 are together a double bond and R 5 is an oxo group.
Streptomyces DSM 4353 produziert die Verbindung der Formel I, in der R1 eine Oxogruppe, R2 eine Methylgruppe, R3 undStreptomyces DSM 4353 produces the compound of formula I in which R 1 is an oxo group, R 2 is a methyl group, R 3 and
R4 Wasserstoff sowie R5 eine Hydroxygruppe sind.R 4 is hydrogen and R 5 is a hydroxy group.
Die erfindungsgemäß verwendeten Streptomyceten-Stämme können wie folgt charakterisiert werden: The streptomycete strains used according to the invention can be characterized as follows:
DSM 4351 DSM 4354 DSM 4353DSM 4351 DSM 4354 DSM 4353
Sporenfarbe: Grau Grau Grau Sporenkette: gerade bis gerade bis enge Spirale gewellt gewelltSpore color: gray gray gray spore chain: straight to straight to narrow spiral wavy wavy
Sporenoberfläche: glatt glatt glatt Melanin: + + + Pigmentbildung :Spore surface: smooth smooth smooth melanin: + + + pigment formation:
Substratmycel: Endo: - - -Substrate mycelium: Endo: - - -
Exo: - - - Luftmycel: Endo - - -Exo: - - - Luftmycel: Endo - - -
Exo: - - - Zucker- und Zuckeralkoholverwertung: Arabinose,Exo: - - - Sugar and sugar alcohol utilization: arabinose,
Xylose,Xylose,
Rhamnose,Rhamnose,
Raffinose,Raffinose,
Mannit,Mannitol,
Inositol,Inositol,
Fructose,Fructose,
SaccharoseSucrose
Anstelle der genannten Stämme können auch jeweils deren Mutanten und Varianten eingesetzt werden, sofern sie die Verbindung der allgemeinen Formel I synthetisieren. Solche Mutanten können in an sich bekannter Weise durch physikalische Mittel, beispielsweise Bestrahlung, wie mit Ultraviolett- oder Röntgenstrahlen oder chemische Mutagene, wie beispielsweise Ethylmethansulfonat (EMS), N-Methyl-N'- nitro-N-nitroso-guanidin (MNNG) oder 2-Hydroxy-4-methoxybenzophenon (MOB) erzeugt werden.Instead of the strains mentioned, their mutants and variants can also be used, provided they synthesize the compound of the general formula I. Such mutants can be known in a manner known per se by physical means, for example radiation, such as with ultraviolet or X-rays, or chemical mutagens, for example ethyl methanesulfonate (EMS), N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) or 2-Hydroxy-4-methoxybenzophenone (MOB) can be generated.
Als bevorzugte Kohlenstoffquelle für die aerobe Fermentation eignen sich assimilierbare Kohlenhydrate und Zuckeralkohole, wie Glucose, Lactose oder Mannit, sowie kohlenhydrathaltige Naturprodukte, wie Malzextrakt. Als bevorzugte stickstoffhaltige Nährstoffe kommen in Betracht: Aminosäuren, Peptide und Proteine sowie deren Abbauprodukte, wie Peptone oder Tryptone, ferner Fleischextrakte, gemahlene Samen, beispielsweise von Mais, Weizen, Bohnen, Soja oder der Baumwollpflanze, Destillationsrückstände derAssimilable carbohydrates and sugar alcohols, such as glucose, lactose or mannitol, as well as carbohydrate-containing natural products, such as malt extract, are suitable as the preferred carbon source for aerobic fermentation. As preferred Nitrogen-containing nutrients come into consideration: amino acids, peptides and proteins and their breakdown products, such as peptones or tryptones, also meat extracts, ground seeds, for example from corn, wheat, beans, soybeans or the cotton plant, distillation residues of
Alkoholherstellung, Fleischmehle oder Hefeextrakte, aber auch Ammoniumsalze und Nitrate. Außerdem kann die Nährlösung beispielsweise Chloride, Carbonate, Sulfate oder Phosphate der Alkali- oder Erdalkalimetalle, Eisen, Zink und Mangan als zusätzliche anorganische Salze enthalten.Alcohol production, meat flours or yeast extracts, but also ammonium salts and nitrates. In addition, the nutrient solution can contain, for example, chlorides, carbonates, sulfates or phosphates of the alkali or alkaline earth metals, iron, zinc and manganese as additional inorganic salts.
Die Bildung der Verbindung der allgemeinen Formel I verläuft besondes gut in einer Nährlösung, die Haferflocken in Konzentrationen von 0,5 bis 6 % . bevorzugt 2 bis 4 % , Sojamehl in Konzentrationen von 0,1 bis 4 % , bevorzugt 0,5 bis 2 % . sowie Spurenelemente enthält, jeweils bezogen auf das Gewicht der gesamten Nährlösung.The formation of the compound of general formula I proceeds particularly well in a nutrient solution, the oatmeal in concentrations of 0.5 to 6%. preferably 2 to 4%, soy flour in concentrations of 0.1 to 4%, preferably 0.5 to 2%. and contains trace elements, each based on the weight of the entire nutrient solution.
Die Fermentation erfolgt aerob, also beispielsweise submers unter Schütteln oder Rühren in Schüttelkolben oder Fermentern, gegebenenfalls unter Einführen von Luft oder Sauerstoff. Die Fermentation kann in einem Temperaturbereich von etwa 18 bis 40°C, vorzugsweise bei etwa 25 bis 30°C, insbesondere bei 28 bis 30°C erfolgen. Man kultiviert den Mikroorganismus unter den genannten Bedingungen bis die stationäre Phase erreicht ist, etwa 60 bis 120 Stunden, bevorzugt 70 bis 75 Stunden.The fermentation is carried out aerobically, for example submerged with shaking or stirring in shake flasks or fermenters, optionally with the introduction of air or oxygen. The fermentation can take place in a temperature range from about 18 to 40 ° C., preferably at about 25 to 30 ° C., in particular at 28 to 30 ° C. The microorganism is cultivated under the conditions mentioned until the stationary phase is reached, about 60 to 120 hours, preferably 70 to 75 hours.
Vorteilhaft kultiviert man in mehreren Stufen, d.h. man stellt zunächst eine oder mehrere Vorkulturen in einem flüssigen Nährmedium her, die dann in das eigentliche Produktionsmedium, die Hauptkultur, beispielsweise im Volumenverhältnis 1:10, überimpft werden. Die Vorkultur erhält man beispielsweise, indem man ein versportes Mycel in eine Nährlösung überimpft und etwa 48 bis 72 Stunden wachsen läßt. Das versporte Mycel kann erhalten werden, indem man den Stamm etwa 7 Tage auf einem festen oder flüssigen Nährboden, beispielsweise Hefe-Malz-Agar, wachsen läßt.Cultivation is advantageously carried out in several stages, ie one or more precultures are first prepared in a liquid nutrient medium, which are then inoculated into the actual production medium, the main culture, for example in a volume ratio of 1:10. The preculture is obtained, for example, by inoculating a spilled mycelium in a nutrient solution and allowing it to grow for about 48 to 72 hours. The exported mycelium can be obtained by using the Let the strain grow on a solid or liquid culture medium, for example yeast-malt agar, for about 7 days.
Der Fermentationsverlauf kann anhand des pH-Wertes der Kultur oder des Mycelvolumens, durch Dünnschichtchromatographie oder Ausprüfen der biologischen Aktivität überwacht werden.The course of the fermentation can be monitored on the basis of the pH value of the culture or the mycelium volume, by thin-layer chromatography or by testing the biological activity.
Die Isolierung der Cyclite der allgemeinen Formel I aus dem Kulturmedium erfolgt nach bekannten Methoden unter Berücksichtigung der chemischen, physikalischen und biologischen Eigenschaften der Produkte. Die Cyclite der allgemeinen Formel I liegen im Mycel bzw. in der Kulturbrühe vor. Sie können aus der unfiltrierten Kulturbrühe mit einem mit Wasser nicht oder nur wenig mischbaren organischen Lösemittel, wie Chloroform oder Ethylacetat, extrahiert werden. Da sie sich jedoch nur zu einem geringen Teil im Mycel befinden, ist es vorteilhaft, die Kulturbrühe vom Mycel zu trennen, beispielsweise durch Zentrifugieren oder Filtrieren, vorzugsweise unter Zugabe vonThe cyclites of the general formula I are isolated from the culture medium by known methods, taking into account the chemical, physical and biological properties of the products. The cyclites of the general formula I are present in the mycelium or in the culture broth. They can be extracted from the unfiltered culture broth with an organic solvent which is immiscible or only slightly miscible with water, such as chloroform or ethyl acetate. However, since they are only a small part of the mycelium, it is advantageous to separate the culture broth from the mycelium, for example by centrifuging or filtering, preferably with the addition of
Filterhilfsmitteln. Die Verbindung der allgemeinen Formel I kann dann aus dem Überstand bzw. Filtrat isoliert werden, zweckmäßig im leicht sauren bis neutralen pH-Bereich, vorzugsweise bei pH 6 bis 7. Dazu kann man mit Wasser wenig oder nicht mischbare organische Lösemittel verwenden, insbesondere chlorierte Kohlenwasserstoff, wie Chloroform oder Methylenchlorid oder Ester wie Ethylacetat oder Aceton. Die Extrakte werden, gegebenenfalls nach Eindampfen und Aufnehmen in einem polaren organischen Lösemittel, durch Fällen mit einem unpolaren Lösemittel, zweckmäßig einem Kohlenwasserstoff wie Petrolether, von stark lipophilen Bestandteilen befreit, die bis zu etwa 80 % des Gesamtextraktes ausmachen können. Aus dem Rückstand können die Cyclite durch Chromatographie isoliert werden.Filter aids. The compound of general formula I can then be isolated from the supernatant or filtrate, expediently in the slightly acidic to neutral pH range, preferably at pH 6 to 7. For this purpose, it is possible to use organic solvents which are poorly or immiscible with water, in particular chlorinated hydrocarbon such as chloroform or methylene chloride or esters such as ethyl acetate or acetone. The extracts, if appropriate after evaporation and taking up in a polar organic solvent, are freed from strongly lipophilic constituents by precipitation with a non-polar solvent, advantageously a hydrocarbon such as petroleum ether, which can make up to about 80% of the total extract. The cyclites can be isolated from the residue by chromatography.
Anstelle einer Extraktion können die Cyclite auch durch Adsorption an handelsüblichen Adsorberharzen aus der Kulturbrühe isoliert werden. Es hat sich ebenfalls als günstig erwiesen, den genannten Fermenterinhalt zu trocknen, beispielsweise durch Sprühtrocknen oder Gefriertrocknen.Instead of an extraction, the cyclites can also be obtained from the adsorber resins by adsorption onto commercially available resins Culture broth are isolated. It has also proven advantageous to dry the fermenter content mentioned, for example by spray drying or freeze drying.
Zur Isolierung der reinen Cyclite können die üblichen Verfahrensschritte Verwendung finden, wie Chromatographie, Gelfiltration oder Fällung aus ihren Lösungen in geeigneten organischen Lösemitteln. Besonders bewährt hat sich eine Chromatographie an Kieselgel, wobei als Laufmittel eine Mischung aus Essigester und Hexan in einem Volumenverhältnis von beispielsweise 1:2 Verwendung findet.The usual process steps can be used to isolate the pure cyclites, such as chromatography, gel filtration or precipitation from their solutions in suitable organic solvents. Chromatography on silica gel has proven particularly useful, a mixture of ethyl acetate and hexane in a volume ratio of, for example, 1: 2 being used as the eluent.
Die Cyclite der allgemeinen Formel I sind ölig und gut in Methanol, Aceton, DMSO, Dioxan und Chloroform löslich, jedoch wenig in Wasser und nicht in Alkanen. Die Substanzen sind im festen Zustand wie auch als Lösung im pH-Bereich von 3 bis 9, insbesondere von 5 bis 8, stabil. Die wachstumsregulierende Wirkung kann besonders gut an zweikeimblättrigen Pflanzen wie Kresse gezeigt werden.The cyclites of the general formula I are oily and readily soluble in methanol, acetone, DMSO, dioxane and chloroform, but little in water and not in alkanes. The substances are stable in the solid state and also as a solution in the pH range from 3 to 9, in particular from 5 to 8. The growth-regulating effect can be shown particularly well on dicotyledonous plants such as cress.
Beispiele:Examples:
1. Fermentation der Produzentenstämme DSM 4351, DSM 4354 und DSM 43531. Fermentation of the producer strains DSM 4351, DSM 4354 and DSM 4353
a) Herstellung einer Sporensuspension eines Produzentenstammes: 100 ml Nährlösung (4 g Hefeextrakt, 10 g Malzextrakt, 4 g Glucose, 1 1 Leitungswasser, pH-Wert vor dem Sterilisieren 7,3) in einem 500 ml Erlenmeyerkolben werden mit dem Stamm beimpft und 72 Stunden bei 27°C und 120 UpM auf der rotierenden Schüttelmaschine inkubiert. Anschließend werden 20 ml Kulturflüssigkeit in einem 500 ml Erlenmeyerkolben mit dem Nährboden der oben genannten Zusammensetzung, dem 20 g Agar/1 zur Verfestigung zugegeben wurde, gleichmäßig verteilt und dekantiert. Die Kulturen werden 10 bis 14 Tage bei 27°C inkubiert. Die nach dieser Zeit entstandenen Sporen eines Kolbens werden mit 500 ml entionisiertem Wasser, das einen Tropfen eines handelsüblichen nichtionischen Tensids enthält, abgeschwemmt, sofort weiterverwendet oder bei -22°C aufbewahrt.a) Preparation of a spore suspension of a producer strain: 100 ml nutrient solution (4 g yeast extract, 10 g malt extract, 4 g glucose, 1 1 tap water, pH before sterilization 7.3) in a 500 ml Erlenmeyer flask are inoculated with the strain and 72 Incubated for hours at 27 ° C and 120 rpm on the rotating shaker. Subsequently, 20 ml of culture liquid in a 500 ml Erlenmeyer flask with the nutrient medium of the above composition, to which 20 g of agar / 1 was added for solidification, are uniform distributed and decanted. The cultures are incubated at 27 ° C for 10 to 14 days. The spores of a flask formed after this time are washed off with 500 ml of deionized water, which contains a drop of a commercially available nonionic surfactant, used immediately or kept at -22 ° C.
b) Herstellung einer Kultur bzw. Vorkultur eines Produzentenstammen im Erlenmeyerkolben:b) Production of a culture or preculture of a producer strain in the Erlenmeyer flask:
Ein 500 ml Erlenmeyerkolben mit 100 ml einer Nährlösung der Zusammensetzung 2 % Fleischmehl, 10 % Malzextrakt, 1 % Calciumcarbonat und Wasser ad 100 % (pH 7.2 vor dem Autoklavieren) wird mit einer auf einem Schrägröhrchen gezogenen Kultur oder mit 0,2 ml Sporensuspension angeimpft und auf einer Schüttelmaschine bei 120 UpM und 27°C inkubiert. Die maximale Produktion des gewünschten Stoffes ist nach 72 Stunden erreicht. Zum Animpfen von 10 und 100 1 Fermentern genügt eine 48 Stunden alte Submerskultur (5 % ) aus der gleichen Nährlösung.A 500 ml Erlenmeyer flask with 100 ml of a nutrient solution of the composition 2% meat meal, 10% malt extract, 1% calcium carbonate and water ad 100% (pH 7.2 before autoclaving) is inoculated with a culture drawn on a slant tube or with 0.2 ml spore suspension and incubated on a shaker at 120 rpm and 27 ° C. The maximum production of the desired substance is reached after 72 hours. A 48 hour old submerged culture (5%) from the same nutrient solution is sufficient to inoculate 10 and 100 1 fermenters.
c) Herstellung der Cyclite:c) Preparation of the Cyclites:
Ein 10 1 Fermenter wird unter folgenden Bedingungen betrieben:A 10 1 fermenter is operated under the following conditions:
Nährmedium: 2 % HaferflockenCulture medium: 2% oatmeal
0,5 % Sojamehl 0,25 % Spurenelemente0.5% soy flour 0.25% trace elements
Spurenelemente: 3 g/1 CaCl.2H2OTrace elements: 3 g / 1 CaCl.2H 2 O
1 g/1 FeC6O7H1 g / 1 FeC 6 O 7 H
0,2 g/1 MnSO4 0.2 g / 1 MnSO 4
0,1 g/1 ZnCl2 0.1 g / 1 ZnCl 2
0,025 g/1 CuSO4.5H2O0.025 g / 1 CuSO 4 .5H 2 O
0,02 g/1 Na2B4O7.10H2O0.02 g / 1 Na 2 B 4 O 7 .10H 2 O
0,004 g/1 CoCl2 0.004 g / 1 CoCl 2
0,01 g/1 Na2MoO4.2H2O0.01 g / 1 Na 2 MoO 4 .2H 2 O
pH 7,2 Inkubationszeit: 72 StundenpH 7.2 Incubation time: 72 hours
Inkubationstemperatur: 30°CIncubation temperature: 30 ° C
Rührergeschwindigkeit : 250 UpMStirrer speed: 250 rpm
Belüftung: 4 1 Luft/Min.Ventilation: 4 1 air / min.
Durch wiederholte Zugabe weniger Tropfen ethanolischer Polyollösung kann die Schaumentwicklung unterdrückt werden, Das Produktionsmaximum wird nach ca. 70 Stunden (pH = 5,3) erreicht. Die Ausbeuten liegen bei ca. 20 mg/1.The foam development can be suppressed by repeatedly adding a few drops of ethanolic polyol solution. The production maximum is reached after approx. 70 hours (pH = 5.3). The yields are approx. 20 mg / 1.
2. Isolierung der Cyclite2. Isolation of the cyclite
Nach der Fermentation der Produzentenstämme wird die Kulturbrühe unter Zusatz von 2 % Celite als Filterhilfsmittel filtriert. Das Mycel wird mit Aceton extrahiert, die organische Phase eingedampft und der wäßrige Rückstand mit Ethylacetat extrahiert. Das Kulturfiltrat wird getrocknet und in MeOH gelöst. Das Rohprodukt wird an einer Kieselgelsäule (Kieselgel 60, Macherey-Nagel) mit Essigester/Hexan (1:2; v:v) chromatographiert.After fermentation of the producer strains, the culture broth is filtered with the addition of 2% Celite as a filter aid. The mycelium is extracted with acetone, the organic phase is evaporated and the aqueous residue is extracted with ethyl acetate. The culture filtrate is dried and dissolved in MeOH. The crude product is chromatographed on a silica gel column (silica gel 60, Macherey-Nagel) with ethyl acetate / hexane (1: 2; v: v).
3. Charakterisierung der Cyclite3. Characterization of the cyclites
a) Charakterisierung der Verbindung:a) Characterization of the compound:
Dünnschichtchromatographie: Kieselgel 60, F254 Thin layer chromatography: silica gel 60, F 254
- Chloroform-Methanol (9:l;v:v): Rf 0,30- chloroform-methanol (9: 1; v: v): Rf 0.30
- n-Butanol-Essigsäure-Wasser, obere Phase (4:1:5; v:v:v) Rf 0,47- n-butanol-acetic acid-water, upper phase (4: 1: 5; v: v: v) Rf 0.47
EI-MS (70 eV): m/e = 160 (M+2H); 140 (M-H2O) entsprechend C7H10O4 (158.16) IR (KBr): 3200-3600, 1715, 1680, 1640 cm-1 EI-MS (70 eV): m / e = 160 (M + 2H); 140 (MH 2 O) corresponding to C 7 H 10 O 4 (158.16) IR (KBr): 3200-3600, 1715, 1680, 1640 cm -1
UV (Methanol): λmax (log ε) = 242 (3,47) nm 1H-NMR (200 MHz, d6-DSMO): δ = 1,70 (t, 3H, J ≈ 1 Hz, 2-CH3); 3,71 (ddd, 1H, J = 8,0/4,5/~5 Hz, 4-H); 4,23 (dd, 1H, J = 8,0/5,0 Hz); 4,34 (breit, 1H); 4,91 (d, 1H, J ≈ 4 Hz, tauscht aus, OH); 5,04 (d, 1H, J ≈ 5 Hz, tauscht aus, 4-OH); 5,37 (d, 1H, J ≈ 5,0 Hz, tauscht aus, OH); 6,65 (d, breit, 1H, J = 4,5 Hz, 3-H) ppm.UV (methanol): λ max (log ε) = 242 (3.47) nm 1 H-NMR (200 MHz, d 6 -DSMO): δ = 1.70 (t, 3H, J ≈ 1 Hz, 2- CH 3 ); 3.71 (ddd, 1H, J = 8.0 / 4.5 / ~ 5 Hz, 4-H); 4.23 (dd, 1H, J = 8.0 / 5.0 Hz); 4.34 (broad, 1H); 4.91 (d, 1H, J ≈ 4 Hz, exchanges, OH); 5.04 (d, 1H, J ≈ 5 Hz, exchanges, 4-OH); 5.37 (d, 1H, J ≈ 5.0 Hz, exchanges, OH); 6.65 (d, broad, 1H, J = 4.5 Hz, 3-H) ppm.
13C-NMR (50,3 MHz, d6-DMSO): δ = 14,8 q (2-CH3); 67,6 d; 75,3 d; 76,4 d; 131,8 s (C-2); 145,3 d (C-3); 199,1 s (C-1) ppm. 13 C NMR (50.3 MHz, d 6 -DMSO): δ = 14.8 q (2-CH 3 ); 67.6 d; 75.3 d; 76.4 d; 131.8 s (C-2); 145.3 d (C-3); 199.1 s (C-1) ppm.
[ a] 2 D 0 (c=1, Methanol) -132°[a] 2 D 0 (c = 1, methanol) -132 °
Charakterisierung der VerbindungCharacterization of the connection
Dünnschichtchromatographie: Kieselgel 60, F254 Thin layer chromatography: silica gel 60, F 254
- Chloroform-Methanol (9:1, v:v): Rf 0,30Chloroform-methanol (9: 1, v: v): Rf 0.30
- n-Butanol-Essigsäure-Wasser, obere Phase (4:1:5; v:v:v): Rf 0,50- n-butanol-acetic acid-water, upper phase (4: 1: 5; v: v: v): Rf 0.50
EI-MS (70 eV): m/e = 160 (M+, 9 % ) ; 124 (11 %) ; 100 (6 % ) , 88 (36 % ) ; 87 (57 % ) ; 73 (100 % ) entsprechend C7H12O4 (160,17)EI-MS (70 eV): m / e = 160 (M + , 9%); 124 (11%); 100 (6%), 88 (36%); 87 (57%); 73 (100%) corresponding to C 7 H 12 O 4 (160.17)
IR (Film): 3200-3500, 1720 cm-1 1H-NMR (200 MHz, CD3OD): δ = 1,03 (d, 3H, J = 6,5 Hz, 2-CH3); 1,42 (dt, 1H, J = 13,8/13,7/2,2 Hz, 3-Ha); 2,12 (ddd, 1H, J = 13,8/5,7/3,7 Hz, 3-Hb); 2,93 (ddq, 1H, J = 13,7/6,5/5,7 Hz, 2-H); 3,48 (dd, 1H, J = 10/3 Hz, 5-H); 4,12 (ddd, 1H, J = 3/3/3 Hz, 4-H); 4,43 (d, 1H, J = 10 Hz, 6-H) ppm.IR (film): 3200-3500, 1720 cm -1 1 H NMR (200 MHz, CD 3 OD): δ = 1.03 (d, 3H, J = 6.5 Hz, 2-CH 3 ); 1.42 (dt, 1H, J = 13.8 / 13.7 / 2.2 Hz, 3-H a ); 2.12 (ddd, 1H, J = 13.8 / 5.7 / 3.7 Hz, 3-H b ); 2.93 (ddq, 1H, J = 13.7 / 6.5 / 5.7 Hz, 2-H); 3.48 (dd, 1H, J = 10/3 Hz, 5-H); 4.12 (ddd, 1H, J = 3/3/3 Hz, 4-H); 4.43 (d, 1H, J = 10 Hz, 6-H) ppm.
13C-NMR (50,3 MHz, CDC13): δ = 13,2 q (CH3); 36,4 t (C-3); 36,7 d (C-2); 68,3 d; 77,1 d; 78,2 d; 210,5 s (C-1) ppm. 13 C NMR (50.3 MHz, CDC1 3 ): δ = 13.2 q (CH 3 ); 36.4 t (C-3); 36.7 d (C-2); 68.3 d; 77.1 d; 78.2 d; 210.5 s (C-1) ppm.
[α]2 D 0 (c=0.497, Methanol) + 93º[α] 2 D 0 (c = 0.497, methanol) + 93 °
Charakterisierung der VerbindungCharacterization of the connection
Dünnschichtchromatographie: Kieselgel 60, F254 Thin layer chromatography: silica gel 60, F 254
- Chloroform-Methanol (9:1, v:v): Rf 0,22Chloroform-methanol (9: 1, v: v): Rf 0.22
- n-Butanol-Essigsäure-Wasser, obere Phase (4:1:5; v:v:v): Rf 0,64- n-butanol-acetic acid-water, upper phase (4: 1: 5; v: v: v): Rf 0.64
EI-MS (70 eV): m/e = 156 (C7H8O4, M+-C2H2O-H2O); 138 (22 %); 96 (66 %); 68 (36 %); 43 (100 %).EI-MS (70 eV): m / e = 156 (C 7 H 8 O 4 , M + -C 2 H 2 OH 2 O); 138 (22%); 96 (66%); 68 (36%); 43 (100%).
IR (Film): 3360, 2920, 2850, 1735, 1680 cm-1 IR (film): 3360, 2920, 2850, 1735, 1680 cm -1
1H-NMR (200 MHz, CD3OD): δ = 2,15 (s, 3H, 9-H3); 3,67 (dd, 1H, J = 8,4/11 Hz, 5-H); 4,08 (d, 1H, J = 11 Hz); 4,45 (d, breit, 1H, J = 8,4/1 Hz); 4,98 (m, 2H, 7-H2); 6,04 (dd, 1H, J = 1,8/1 Hz, 2-H) ppm. 1 H NMR (200 MHz, CD 3 OD): δ = 2.15 (s, 3H, 9-H 3 ); 3.67 (dd, 1H, J = 8.4 / 11 Hz, 5-H); 4.08 (d, 1H, J = 11 Hz); 4.45 (d, broad, 1H, J = 8.4 / 1H z ); 4.98 (m, 2H, 7-H 2); 6.04 (dd, 1H, J = 1.8 / 1 Hz, 2-H) ppm.
13 C-NMR (50,3 MHz, CD3OD): δ = 20,6 q; 63,7 t; 73,4 d; 78,0 d; 79,3 d; 122,5 d; 161,5 s; 172,0 s; 199,2 s ppm. [α]20 (c=1, Methanol) -34º D13 C NMR (50.3 MHz, CD 3 OD): δ = 20.6 q; 63.7 t; 73.4 d; 78.0 d; 79.3 d; 122.5 d; 161.5 s; 172.0 s; 199.2 s ppm. [α] 20 (c = 1, methanol) -34 ° D
Charakterisierung der VerbindungCharacterization of the connection
Dünnschichtchromatographie: Kieselgel 60 F254 Thin layer chromatography: silica gel 60 F 254
- Chloroform-Methanol (9:1, v:v): Rf 0,17Chloroform-methanol (9: 1, v: v): Rf 0.17
- n-Butanol-Essigsäure-Wasser, obere Phase (4:1:5; v:v:v) Rf 0,54- n-butanol-acetic acid-water, upper phase (4: 1: 5; v: v: v) Rf 0.54
EI-MS (70 eV): m/e = 140 (C7H8O3, M-H2O); 98 (100 % ).EI-MS (70 eV): m / e = 140 (C 7 H 8 O 3 , MH 2 O); 98 (100%).
IR (Film): 3460, 2930, 2850, 1670 cm-1 IR (film): 3460, 2930, 2850, 1670 cm -1
1H-NMR (200 MHz, CD3OD): δ = 2,09 (s, breit, 3H, CH3); 3,58 (dd, 1H, J = 11,2/8,8 Hz, 5-H); 4,01 (d, 1H, J = 11,2 Hz); 4,25 (d, 1H, J = 8,8 Hz); 5,96 (s, breit, 1H, 2-H) ppm 1 H NMR (200 MHz, CD 3 OD): δ = 2.09 (s, broad, 3H, CH 3 ); 3.58 (dd, 1H, J = 11.2 / 8.8 Hz, 5-H); 4.01 (d, 1H, J = 11.2 Hz); 4.25 (d, 1H, J = 8.8 Hz); 5.96 (s, broad, 1H, 2-H) ppm
13C-NMR (50,3 MHz, CD3OD): δ = 20,1 q; 75,2 d; 78,1 d; 79,2 d; 125,7 d; 165,7 s; 199,4 s ppm. 13 C NMR (50.3 MHz, CD 3 OD): δ = 20.1 q; 75.2 d; 78.1 d; 79.2 d; 125.7 d; 165.7 s; 199.4 s ppm.
[α]2 D 0 (c=1, Methanol) -48° [α] 2 D 0 (c = 1, methanol) -48 °

Claims

Patentansprüche : Claims:
1 . Ve rbindung de r allgemeinen Formel I ,1 . Compound of the general formula I,
in der unabhängig voneinanderin the independently of each other
R1 eine Oxogruppe oder eine Hydroxygruppe, R2 eine Methylgruppe oder eine Acetoxymethylgruppe, R3 und R4 Wasserstoff oder gemeinsam eine Doppelbindung undR 1 is an oxo group or a hydroxyl group, R 2 is a methyl group or an acetoxymethyl group, R 3 and R 4 are hydrogen or together a double bond and
R5 eine Oxogruppe oder eine Hydroxygruppe sind, ausgenommen die Verbindung, in derR 5 are an oxo group or a hydroxy group, except for the compound in which
R1 eine Oxogruppe, R2 eine Methylgruppe, R3 und R4 Wasserstoff undR 1 is an oxo group, R 2 is a methyl group, R 3 and R 4 are hydrogen and
R5 eine Hydroxygruppe ist und die den Drehwert [α]20 -106° DR 5 is a hydroxyl group and has the rotation value [α] 20 -106 ° D
(Methanol, c=0,45) hat.(Methanol, c = 0.45).
2. Verfahren zur Herstellung der Verbindung nach Anspruch 1, dadurch gekennzeichnet, daß die Streptomycetenstämme2. A process for the preparation of the compound according to claim 1, characterized in that the streptomycete strains
DSM 4351, DSM 4354 und DSM 4353 kultiviert werden bis sich die genannte Verbindung in der Nährlösung anhäuft.DSM 4351, DSM 4354 and DSM 4353 are cultivated until the compound mentioned accumulates in the nutrient solution.
3. Verfahren nach Anspruch 2, dadurch gekennzeichnet, daß die Nährlösung Haferflocken in Konzentrationen von 0,5 bis 6 % und Sojamehl in Konzentrationen von 0,1 bis 4 % , jeweils bezogen auf das Gewicht der gesamten Nährlösung, enthält.3. The method according to claim 2, characterized in that the nutrient solution contains oatmeal in concentrations of 0.5 to 6% and soy flour in concentrations of 0.1 to 4%, each based on the weight of the entire nutrient solution.
4. Verfahren nach Anspruch 3, dadurch gekennzeichnet, daß die Nährlösung 2 bis 4 % Haferflocken und 0,5 bis 2 % Sojamehl enthält. 4. The method according to claim 3, characterized in that the nutrient solution contains 2 to 4% oatmeal and 0.5 to 2% soy flour.
5. Verfahren nach einem oder mehreren der Ansprüche 2 bis 4, dadurch gekennzeichnet, daß die Kultivierung in einem Temperaturbereich von 18 bis 40°C erfolgt.5. The method according to one or more of claims 2 to 4, characterized in that the cultivation takes place in a temperature range of 18 to 40 ° C.
6. Die Verwendung der Verbindung nach Anspruch 1 als wachstumsregulierender Stoff.6. The use of the compound of claim 1 as a growth regulating substance.
7. Streptomyces DSM 4351, DSM 4354 und DSM 4353 sowie deren Mutanten und Varianten, sofern sie die Verbindung nach Anspruch 1 produzieren. 7. Streptomyces DSM 4351, DSM 4354 and DSM 4353 and their mutants and variants, provided that they produce the compound according to claim 1.
EP19890906108 1988-06-01 1989-05-13 New cyclites derived from streptomycetes, their preparation and use Withdrawn EP0417152A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3818577 1988-06-01
DE3818577 1988-06-01

Publications (1)

Publication Number Publication Date
EP0417152A1 true EP0417152A1 (en) 1991-03-20

Family

ID=6355567

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890906108 Withdrawn EP0417152A1 (en) 1988-06-01 1989-05-13 New cyclites derived from streptomycetes, their preparation and use

Country Status (3)

Country Link
EP (1) EP0417152A1 (en)
JP (1) JPH03504600A (en)
WO (1) WO1989012038A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8912038A1 *

Also Published As

Publication number Publication date
JPH03504600A (en) 1991-10-09
WO1989012038A1 (en) 1989-12-14

Similar Documents

Publication Publication Date Title
DE3242849C2 (en)
DE3783588T2 (en) NEW DC-88A AND DC-89A1 CONNECTIONS AND THEIR PRODUCTION METHOD.
DE4320023A1 (en) Holotype strain Aspergillus obscurus - for cultivation of mevinolin in the form of lactone or open hydroxy carboxylic acid for reduction of cholesterol levels
EP0318849A2 (en) Manumycin derivatives, process for their preparation and their use
DE3521436C2 (en)
CH640270A5 (en) METHOD FOR PRODUCING THE ANTIBIOTIC C-15003 P-3.
EP0333024B1 (en) 10-Ring lactones, process for their preparation and their use
DE3512194A1 (en) A NEW ANSAMYCIN ANTIBIOTIC, A MICROBIAL PROCESS FOR PRODUCING IT AND ITS USE AS A MEDICINAL PRODUCT
EP0342363A2 (en) Angucyclinones from streptomyces, process to obtain them and their use
EP0337152A1 (en) Furans and lactones from streptomycetes, process for their preparation and their use
DE2028403C3 (en) Pepstatin
DE60128565T2 (en) POLYCYCLIC XANTHONE AS ANTIBIOTICS
DE2839668C2 (en)
DE3234203A1 (en) MACBECIN DERIVATIVES AND THEIR PRODUCTION
CH631740A5 (en) Process for the preparation of maytansinol and its derivatives
EP0652205A2 (en) Moenomycin degradation products containing hydroxylated or oxidized lateral lipid chain and moenomycin analogs, process for preparing and their use
CH640269A5 (en) Method for producing the antibiotic c-15003 p. 4
EP0182208B1 (en) Urdamycines, their preparation, streptomyces for their preparation and their use
EP0417152A1 (en) New cyclites derived from streptomycetes, their preparation and use
DE2746209C2 (en)
EP0339442A2 (en) Angucyclinones from streptomyces, process to obtain them and their use
EP0259778B1 (en) Antibiotically effective gentisine acid derivative
EP0660825B1 (en) Anti-inflammatory macrolactam (cyclamenol)
DE69217000T2 (en) Antibacterial compound BE-24566B
EP0304400B1 (en) Phenanthridine derivatives, process for their preparation and medium for performing the process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19901123

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19930113